HOTAIR has been demonstrated to be upregulated in breast cancer, hepatocellular carcinoma, pancreatic cancer, laryngeal squamous cell carcinoma and colorectal cancer [12], [15], [16], [18], [20]–[23], [25], [26]. This evidence concerns the gene HOTAIR and familial pancreatic carcinoma.